Nexentis Technologies旗下Mitocarex发现更多符合Mitoline规则的Slc蛋白

美股速递
Jun 17

Nexentis Technologies Inc. 宣布,其旗下公司Mitocarex在研究中取得新进展,识别出了更多符合“Mitoline”规则集的溶质载体蛋白。这一发现有望为基于该技术平台的新药研发提供更广阔的目标选择空间。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10